10x Science raises $4.8M to help drug makers sort through AI-generated molecules and pick winners

10x Science closed a $4.8 million seed funding round to build software that helps pharmaceutical researchers evaluate molecules discovered by AI. AI tools can now generate thousands of candidate drug compounds in days, but researchers lack a fast way to decide which ones are worth testing in the lab — creating a bottleneck that slows drug development.